Richard Nause
About Richard Nause
Richard Nause is the Director of Drug Product Development - Small Molecules at Bristol-Myers Squibb, with extensive experience in pharmaceutical product development and a strong background in polymer science and engineering.
Title and Current Role
Richard Nause currently serves as the Director of Drug Product Development for Small Molecules at Bristol-Myers Squibb. He works in the Greater New York City Area, focusing on the advancement of pharmaceutical product development, specifically in solid oral formulation. His comprehensive background in polymer science and engineering enhances his role at the company, contributing to his expertise in managing complex drug development processes.
Past Roles in the Pharmaceutical Industry
Richard Nause has held multiple key roles in the pharmaceutical industry throughout his career. From 2017 to 2019, he was the Associate Director for Commercial Drug Product Development at Celgene in Summit, NJ. Prior to that, he was a Principal Engineer in Process Development at Celgene from 2015 to 2017. He has also worked as a Senior Process Engineer at GSK for one year and served as a Principal Scientist at Novartis for five years. His earlier roles include positions as a Senior Scientist at Pfizer and as a Technician at The Mississippi Polymer Institute.
Educational Background
Richard Nause earned his Ph.D. in Polymer Science and Engineering from the University of Massachusetts Amherst, where he studied from 1998 to 2004. Before that, he obtained a B.S. in Polymer Science from the University of Southern Mississippi, completing his undergraduate degree from 1994 to 1998. His educational background has provided him with a strong foundation in polymer science, which is crucial for his work in pharmaceutical product development.
Specializations in Drug Product Development
Richard Nause specializes in the development of pharmaceutical solid oral formulations. His expertise includes the creation of complex solid dosage forms such as amorphous dispersion, controlled release, multiparticulates, spray drying, melt extrusion, osmotic tablets, and pediatric formulations. He possesses strong technical leadership capabilities and has a proven track record in drug product process development and technology transfer.
Expertise in Quality by Design (QBD) and Design of Experiments (DoE)
Richard Nause is well-versed in the implementation and analysis of Quality by Design (QBD) and Design of Experiments (DoE) methodologies. These skills are instrumental in ensuring the robustness and efficiency of drug product development processes. His proficiency in controlled release and modified release formulation development further underscores his expertise in pharmaceutical research and development.